Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Operating Expenses | 3,620 | 5,010 | 5,880 | 8,630 | 7,730 |
| Operating Income | -3,620 | -5,010 | -5,880 | -8,630 | -7,730 |
| Other Income | -9,910 | 7,540 | -5,140 | 1,160 | 790 |
| Pre-tax Income | -13,530 | 2,530 | -11,020 | -7,470 | -6,940 |
| Net Income Continuous | -13,536 | 2,537 | -11,028 | -7,428 | -16,858 |
| Net Income | $-13,536 | $2,537 | $-11,028 | $-7,428 | $-16,858 |
| EPS Basic Total Ops | -40.82 | 9.60 | -40.82 | -28.81 | -67.23 |
| EPS Basic Continuous Ops | -41.71 | 8.76 | -41.09 | -28.54 | -68.50 |
| EPS Diluted Total Ops | -40.82 | 9.60 | -40.82 | -28.81 | -67.23 |
| EPS Diluted Continuous Ops | -41.71 | 8.76 | -41.09 | -28.54 | -68.50 |
| EBITDA(a) | $-3,570 | $-4,960 | $-5,830 | $-8,570 | $-7,630 |